Cargando…

Genetic Factors Involved in the Development and Progression of Nonalcoholic Fatty Liver Disease

Purpose. The aim of our study was to identify the possible involvement of adiponutrine polymorphysm and of human leukocyte antigens (HLA) in the development of non-alcoholic fatty liver disease (NAFLD). Material and Methods. We included in this study a total of 138 subjects with non-invasive diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales:	AMZOLINI, A.M., FORTOFOIU, M., TUDORICA-MICU, S.E., FORTOFOIU, M.C., NEAGOE, D., POPESCU, M., BURADA, F., VERE, C.C., CIUREA, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medical University Publishing House Craiova 2015
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243520/ https://www.ncbi.nlm.nih.gov/pubmed/30538833 http://dx.doi.org/10.12865/CHSJ.41.04.01

Ejemplares similares

Insulin Resistance and Chronic Kidney Disease in Patients with Type 1 Diabetes Mellitus
por: Vladu, Mihaela, et al.
Publicado: (2017)

Triglyceride and Glucose Index as a Screening Tool for Nonalcoholic Liver Disease in Patients with Metabolic Syndrome
por: Amzolini, Anca Maria, et al.
Publicado: (2022)

Triglyceride and glucose index: a useful tool for non-alcoholic liver disease assessed by liver biopsy in patients with metabolic syndrome?
por: Amzolini, Anca Maria, et al.
Publicado: (2021)

Maternal and Fetal Metabolites in Gestational Diabetes Mellitus: A Narrative Review
por: Vladu, Ionela Mihaela, et al.
Publicado: (2022)

A Study of Biomarkers Associated with Metabolic Dysfunction-Associated Fatty Liver Disease in Patients with Type 2 Diabetes
por: Efrem, Ion Cristian, et al.
Publicado: (2022)

Systemic and adipose tissue inflammation in NASH: correlations with histopathological aspects
por: Micu, Elena Simona, et al.
Publicado: (2021)

Study of Pulmonary Hypertension in Patients Suffering from Chronic Obstructive Pulmonary Disease
por: TUDORAȘCU, D.R., et al.
Publicado: (2016)

Study of the Etiological Spectrum of Spontaneous Bacterial Peritonitis in a Group of Patients Suffering from Liver Cirrhosis
por: TUDORAȘCU, D.R., et al.
Publicado: (2016)

New strategies of diagnostic and therapeutic approach to emergencies in the evolution of patients with diabetes mellitus (Review)
por: Forțofoiu, Maria, et al.
Publicado: (2022)

The Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease
por: Roychowdhury, Sanjoy, et al.
Publicado: (2018)

The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC
por: Rusu, Ioana, et al.
Publicado: (2022)

Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
por: Chackelevicius, Carla Melisa, et al.
Publicado: (2016)

The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice
por: He, Beihui, et al.
Publicado: (2017)

Transient Polyhydramnios during Pregnancy Complicated with Gestational Diabetes Mellitus: Case Report and Systematic Review
por: Preda, Agnesa, et al.
Publicado: (2022)

Are Ingested or Inhaled Microplastics Involved in Nonalcoholic Fatty Liver Disease?
por: Auguet, Teresa, et al.
Publicado: (2022)

Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease
por: Boutari, Chrysoula, et al.
Publicado: (2018)

Recent Progress in the Molecular Imaging of Nonalcoholic Fatty Liver Disease
por: Wegrzyniak, Olivia, et al.
Publicado: (2021)

The Chromatin Accessibility Landscape of Nonalcoholic Fatty Liver Disease Progression
por: Kang, Byeonggeun, et al.
Publicado: (2022)

The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
por: Cazanave, Sophie, et al.
Publicado: (2017)

Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease
por: Kleiner, David E., et al.
Publicado: (2019)

An Update of Medical Nutrition Therapy in Gestational Diabetes Mellitus
por: Vasile, Flavia Cristina, et al.
Publicado: (2021)

Insulin resistance quantified by the value of HOMA-IR and cardiovascular risk in patients with type 2 diabetes
por: Vladu, Ionela Mihaela, et al.
Publicado: (2022)

Analysis of Risk Factors for the Development of Gestational Diabetes Mellitus in a Group of Romanian Patients
por: Preda, Agnesa, et al.
Publicado: (2022)

Genetic predisposition in nonalcoholic fatty liver disease
por: Sookoian, Silvia, et al.
Publicado: (2017)

Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years
por: Kawanaka, Miwa, et al.
Publicado: (2020)

Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes
por: Simeone, Jason C, et al.
Publicado: (2017)

Lipoprotein metabolism in nonalcoholic fatty liver disease
por: Jiang, Zhenghui Gordon, et al.
Publicado: (2013)

The Involvement of Calcium Channels in the Endoplasmic Reticulum Membrane in Nonalcoholic Fatty Liver Disease Pathogenesis
por: Albalawi, Sarah S, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease
por: Younossi, Zobair M., et al.
Publicado: (2017)

Involvement of Periodontal Disease in the Pathogenesis and Exacerbation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: A Review
por: Kobayashi, Takashi, et al.
Publicado: (2023)

Cytopathological Aspects in the Bronchoalveolar Lavage Fluid in Chronic Obstructive Pulmonary Disease
por: PETRESCU, F, et al.
Publicado: (2015)

Role of bioactive fatty acids in nonalcoholic fatty liver disease
por: Juárez-Hernández, Eva, et al.
Publicado: (2016)

Racial Differences in Nonalcoholic Fatty Liver Disease in the U.S. Population
por: Schneider, Andrea L. C., et al.
Publicado: (2013)

Diabetes mellitus and renal involvement in chronic viral liver disease
por: Iovanescu, VF, et al.
Publicado: (2015)

Nonalcoholic fatty liver disease: new treatments
por: Hardy, Timothy, et al.
Publicado: (2015)

Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis
por: Pickett-Blakely, Octavia, et al.
Publicado: (2018)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice
por: Harley, Isaac TW, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j7empi1j1rvrsmrerigf9mkt4o